Project Data Sphere, an independent not-for-profit initiative, has launched a data sharing platform
Project Data Sphere (PDS), an independent not-for-profit initiative has launched a data sharing platform that has been specifically designed to provide one place where the cancer community can broadly share, integrate and analyze historical patient level, comparator arm data from academic and industry phase III cancer clinical trials. The initiative addressed prior obstacles to clinical trial data sharing by working with leading legal and privacy experts, as well as clinicians, commercial institutions and patient representatives to build an optimal framework to share data responsibly.
Initial data sets of de-identified, patient level data, have been provided by AstraZeneca, Bayer, Celgene, Janssen Research and Development, an affiliate of Johnson & Johnson, Memorial Sloan Kettering Cancer Center, Pfizer, and Sanofi US. PDS is currently working with these and other organizations, including the Alliance for Clinical Trials in Oncology (sponsored by the National Cancer Institute), Amgen, and Quintiles to provide additional cancer data sets.
The Project Data Sphere platform was developed by SAS, an industry leader in data security and analytics. State of the art analytic tools are available on demand to registered users within the platform.
Read the full release here.